AEON - AEON Biopharma, Inc.
1.06
0.030 2.830%
Share volume: 40,058
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.14%
PREVIOUS CLOSE
CHG
CHG%
$1.03
0.03
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-12-2024 | 11-13-2024 | 03-24-2025 | 05-14-2025 | 11-14-2025 | |
| Assets | |||||||
| Total Assets | 3.032 M | 5.734 M | 4.004 M | 3.142 M | 13.799 M | 8.734 M | |
| Current Assets | 2.498 M | 4.019 M | 2.371 M | 1.590 M | 12.321 M | 7.412 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 1.558 M | 3.442 M | 537.000 K | 13.000 K | 10.446 M | 5.927 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 307.000 K | 282.000 K | 258.000 K | 235.000 K | 220.000 K | 181.000 K | |
| Other Assets | 227.000 K | 1.433 M | 1.375 M | 1.317 M | 1.258 M | 1.141 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||
| Total Liabilities and shareholders’ equity | 3.032 M | 5.734 M | 4.004 M | 3.142 M | 13.799 M | 8.734 M | |
| Total liabilities | 201.413 M | 33.681 M | 36.094 M | 31.711 M | 25.122 M | 28.606 M | |
| Total current liabilities | 15.957 M | 10.429 M | 10.726 M | 14.149 M | 8.640 M | 8.228 M | |
| Accounts Payable | 6.523 M | 3.030 M | 4.630 M | 5.910 M | 2.437 M | 2.525 M | |
| Other liabilities | 180.369 M | 9.960 M | 10.198 M | 5.873 M | 3.162 M | 3.327 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 5.087 M | 13.292 M | 15.170 M | 11.689 M | 13.320 M | 17.051 M | |
| Other liabilities | 180.369 M | 9.960 M | 10.198 M | 5.873 M | 3.162 M | 3.327 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | -198.381 M | -27.947 M | -32.090 M | -28.569 M | -11.332 M | -19.872 M | |
| Common stock | 393.239 M | 399.561 M | 401.589 M | 403.028 M | 411.170 M | 413.810 M | |
| Retained earnings | -591.620 M | -427.508 M | -433.679 M | -431.597 M | -422.502 M | -433.682 M |